Letter from the Editor


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 558.

Product Description

Ringing in the new year is a time for reflection and with so many pressing issues facing life-sciences companies, business in 2006 is sure to be anything but usual.
In 2005, the industry weathered myriad storms — ranging from major product withdrawals to threats of pandemics to more government controls to increased scrutiny on drug safety and efficacy to the initiation of a complex reimbursement program to billions of dollars in sales lost to patent expirations, and the list goes on and on — all under a cloud of public distrust.
Yet, despite the highly visible critics who took advantage of every consumer media outlet to spew their own agendas and denigrate an industry that often doesn’t receive the credit it deserves, there remains a sense of optimism and a renewed focus on the patient, particularly the baby-boomer patient population…